NASDAQ:AGTC - Applied Genetic Technologies Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$6.45 -0.03 (-0.46 %)
(As of 10/19/2018 04:00 PM ET)
Previous Close$6.45
Today's Range$6.44 - $6.59
52-Week Range$3.25 - $7.50
Volume53,858 shs
Average Volume328,626 shs
Market Capitalization$117.49 million
P/E Ratio-5.47
Dividend YieldN/A
Beta2.06
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's lead products consist of four ophthalmology development programs across three targets, including X-linked retinoschisis that is in Phase I/II clinical trials; X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials for the treatment of inherited retinal diseases, as well as a preclinical program in adrenoleukodystrophy, which is a disease of the central nervous system and otology. It has collaboration agreements with Biogen MA, Inc., 4D Molecular Therapeutics, Synpromics Limited, and Bionic Sight, LLC, as well as the University of Florida Research Foundation. The company was founded in 1999 and is headquartered in Alachua, Florida.

Receive AGTC News and Ratings via Email

Sign-up to receive the latest news and ratings for AGTC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AGTC
CUSIPN/A
Phone386-462-2204

Debt

Debt-to-Equity RatioN/A
Current Ratio7.58
Quick Ratio7.58

Price-To-Earnings

Trailing P/E Ratio-5.47
Forward P/E Ratio-4.06
P/E GrowthN/A

Sales & Book Value

Annual Sales$24.19 million
Price / Sales4.83
Cash FlowN/A
Price / CashN/A
Book Value$5.48 per share
Price / Book1.18

Profitability

EPS (Most Recent Fiscal Year)($1.18)
Net Income$-21,300,000.00
Net Margins-88.06%
Return on Equity-19.77%
Return on Assets-16.57%

Miscellaneous

Employees78
Outstanding Shares18,130,000
Market Cap$117.49 million

Applied Genetic Technologies (NASDAQ:AGTC) Frequently Asked Questions

What is Applied Genetic Technologies' stock symbol?

Applied Genetic Technologies trades on the NASDAQ under the ticker symbol "AGTC."

How were Applied Genetic Technologies' earnings last quarter?

Applied Genetic Technologies Corp (NASDAQ:AGTC) released its quarterly earnings results on Monday, September, 10th. The biotechnology company reported ($0.37) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.17) by $0.20. The biotechnology company earned $5.42 million during the quarter, compared to analyst estimates of $6.87 million. Applied Genetic Technologies had a negative net margin of 88.06% and a negative return on equity of 19.77%. View Applied Genetic Technologies' Earnings History.

When is Applied Genetic Technologies' next earnings date?

Applied Genetic Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, November 6th 2018. View Earnings Estimates for Applied Genetic Technologies.

What price target have analysts set for AGTC?

5 brokerages have issued twelve-month price targets for Applied Genetic Technologies' shares. Their predictions range from $5.00 to $9.00. On average, they expect Applied Genetic Technologies' share price to reach $7.40 in the next twelve months. This suggests a possible upside of 14.7% from the stock's current price. View Analyst Price Targets for Applied Genetic Technologies.

What is the consensus analysts' recommendation for Applied Genetic Technologies?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied Genetic Technologies in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Applied Genetic Technologies.

Who are some of Applied Genetic Technologies' key competitors?

Who are Applied Genetic Technologies' key executives?

Applied Genetic Technologies' management team includes the folowing people:
  • Ms. Susan B. Washer, Pres, CEO & Director (Age 57)
  • Dr. Mark S. Shearman Ph.D., Chief Scientific Officer (Age 58)
  • Mr. Stephen W. Potter, VP & Chief Bus. Officer (Age 62)
  • Dr. Nicholas Muzyczka, Co-Founder
  • Dr. Barry J. Byrne, Co-Founder

How do I buy shares of Applied Genetic Technologies?

Shares of AGTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Applied Genetic Technologies' stock price today?

One share of AGTC stock can currently be purchased for approximately $6.45.

How big of a company is Applied Genetic Technologies?

Applied Genetic Technologies has a market capitalization of $117.49 million and generates $24.19 million in revenue each year. The biotechnology company earns $-21,300,000.00 in net income (profit) each year or ($1.18) on an earnings per share basis. Applied Genetic Technologies employs 78 workers across the globe.

What is Applied Genetic Technologies' official website?

The official website for Applied Genetic Technologies is http://www.agtc.com.

How can I contact Applied Genetic Technologies?

Applied Genetic Technologies' mailing address is 14193 NW 119TH TERRACE SUITE 10, ALACHUA FL, 32615. The biotechnology company can be reached via phone at 386-462-2204.


MarketBeat Community Rating for Applied Genetic Technologies (NASDAQ AGTC)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  313 (Vote Outperform)
Underperform Votes:  182 (Vote Underperform)
Total Votes:  495
MarketBeat's community ratings are surveys of what our community members think about Applied Genetic Technologies and other stocks. Vote "Outperform" if you believe AGTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AGTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel